Delivery Order SPE2DB20D1100-SPE2DB24FD5D6

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,758.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract is for the delivery of 12,000 unit capsules of the drug CREON DR, a prescription medication. This award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and provides a wide range of pharmaceutical...
This federal contract award is a delivery order, valued at $2,411.52, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product. The contract has an ultimate completion date of September 5, 2024 and is a firm fixed-price arrangement. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award is for the delivery of 36,000 units of the pharmaceutical product CREON DR 100S capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $3,111.27. The award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CREON DR 36,000 UNIT CAPSULE UU 100S. The contract is a Delivery Order valued at $2,985.97 with a Firm Fixed Price pricing type. The ultimate completion date for the contract is June 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop...
This federal contract award, valued at $4,540.30, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and the ultimate completion date is May 9, 2024. The contract covers the delivery of 36,000 unit capsules of CREON DR, a pharmaceutical product, to support the DLA's medical supply requirements. This award is part of a larger...
This federal contract award, valued at $2,343.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE 100S. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award, valued at $1,898.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order to provide 12,000 units of the CREON DR 100S capsule product. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to...
This federal contract award is for the delivery of 24,000 units of the pharmaceutical product CREON DR 24,000 UNIT CAPSULE UU 100S to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $1,171.62 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is a delivery order valued at $9,509.08 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 unit capsules of the product "CREON DR" with an ultimate completion date of December 17, 2024. This award is under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,019.10 firm fixed-price delivery order contract is for the supply of 24,000 units of CREON DR 24,000 UNIT CAPSULE UU 100S, with a performance period ending on May 14, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5D6
    Delivery Order

This federal contract award, valued at $2,474.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE in 100-count bottles. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999 and runs through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 29, 2024.

Generated 11/27/24, 9:13 AM